The Health Products Regulatory Authority (HPRA) has issued a safety notice to raise awareness of a product recall of two batches of the Genrui Covid-19 rapid antigen test.

The manufacturer has identified an issue relating to contamination of the sample diluent for two specific batches - 20211008 and 20211125.

The HPRA said these batches are being recalled from affected retailers and members of the public.

The recall follows on from the recent voluntary suspension from sale of the Genrui self-test by retailers in Ireland after the HPRA received over 1,350 reports from consumers of false positive results linked with its use.

The HPRA says that it is continuing to liaise with the manufacturer and the agency's assessment of the issue is ongoing.

The manufacturer has temporarily suspended the sale of Genrui tests to Ireland on a voluntary basis while the recall is ongoing.

The HPRA said that feedback from other European competent authorities indicates that other member states are not experiencing the same high number of reports of false positive results with the Genrui test.